Skip to main content
Caplight Logo









HeartBeat.bio AG

HeartBeat.bio AG

Private
ViennaHealthcare & Life Scienceshttps://www.heartbeat.bio/

Last Round

VC Round

Nov 2, 2023

Total Funding Raised

$6M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

HeartBeat.bio AG is a biotechnology company that develops a high-throughput human organoid and AI-supported drug discovery platform for heart disease.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

organoiddrug discoverycardiac organoidorgan-on-a-chiphigh-throughput screeningtoxicity testingcontract research organizationCROdisease modelingsafety pharmacologyin vitro testingbiotech platformphenotypic screeningassay developmentdrug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HeartBeat.bio AG Comparables

Compare HeartBeat.bio AG with similar companies based on industry and business-model similarity.

HeartBeat.bio AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Genome Biologics
88%
Medera
84%
Valo Health
80%

HeartBeat.bio AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundNov 2, 2023
SeedMay 4, 2021

Key People

Founding team and executive leadership

Florian Fuchs

Chief Technology Officer

Executive Team

HeartBeat.bio AG Investors

Notable investors and investment history

HeartBeat.bio AG investors
InvestorRounds
Vienna Business AgencyGrant
Austria WirtschaftsserviceGrant, Seed, VC Round
FFG Austrian Research Promotion AgencyGrant
INiTSSeed
Invest AGVC Round
Invest AGVC Round
red-stars.com dataSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased to 5, 2.5x the trailing average.

  • Jan 20, 2026

    Monthly visitors grew 106% MoM, reaching 7.5K.

HeartBeat.bio AG Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

HeartBeat.bio AG Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about HeartBeat.bio AG's valuation, stock price, and market status.

Firmographic Details

HeadquartersVienna
Employee Range25
Year Founded2021
Last FundingNov 2, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?